Home Event Unveiling novel mechanisms of resistance to immunotherapy: Tumor intrinsic JAK2 downmodulation leads to IFNg deficient response and acquired resistance to T cell redirection therapies

Date

11 Mar 2021
Expired!

Time

9:30 am - 9:30 am

Unveiling novel mechanisms of resistance to immunotherapy: Tumor intrinsic JAK2 downmodulation leads to IFNg deficient response and acquired resistance to T cell redirection therapies

  • Invited Speaker: Alejandro Martínez-Sabadell (PhD student Growth Factors Group headed by J. Arribas)
  • Talk title: Unveiling novel mechanisms of resistance to immunotherapy: Tumor intrinsic JAK2 downmodulation leads to IFNg deficient response and acquired resistance to T cell redirection therapies